{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T14:54:20Z","timestamp":1784732060951,"version":"3.55.0"},"reference-count":40,"publisher":"Federa\u00e7\u00e3o das Associa\u00e7\u00f5es de Ginecologia e Obstetr\u00edcia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,2]]},"DOI":"10.61622\/rbgo\/2024fps02","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T15:59:31Z","timestamp":1714665571000},"source":"Crossref","is-referenced-by-count":11,"title":["Use of hormones and risk of venous thromboembolism"],"prefix":"10.61622","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5157-1597","authenticated-orcid":false,"given":"Venina Isabel Po\u00e7o Viana Leme de","family":"Barros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0788-5844","authenticated-orcid":false,"given":"Andr\u00e9 Luiz Malavasi Longo de","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0293-3042","authenticated-orcid":false,"given":"Denis Jose do","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6137-9259","authenticated-orcid":false,"given":"Eduardo","family":"Zlotnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9972-402X","authenticated-orcid":false,"given":"Marcelo Melzer","family":"Teruchkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5329-7819","authenticated-orcid":false,"given":"Marcos Ar\u00eaas","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1898-520X","authenticated-orcid":false,"given":"Paulo Francisco Ramos","family":"Margarido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"47794","reference":[{"key":"key20240502115921_B1","author":"World Health Organization","year":"2018","unstructured":"1. World Health Organization, Johns Hopkins Bloomberg School of Public Health. Center for Communication Programs. Family planning: a global handbook for providers: evidence-based guidance developed through worldwide collaboration [Internet]. 3rd ed. Geneva: WHO; 2018 [cited 2020 Dec 12]. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/260156","journal-title":"Family planning: a global handbook for providers: evidence-based guidance developed through worldwide collaboration"},{"issue":"5","key":"key20240502115921_B2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"Trussell","year":"2011","unstructured":"2. Trussell J. Contraceptive failure in the United States. Contraception. 2011;83(5):397-404. doi: 10.1016\/j.contraception.2011.01.021","journal-title":"Contraception"},{"key":"key20240502115921_B3","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study","volume":"339","author":"van Hylckama Vlieg","year":"2009","unstructured":"3. van Hylckama Vlieg A, Hermerhorst FM, Vandenbroucke JP, Doggen CJ, Rosendall FR. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ. 2009;339:b2921. doi: 10.1136\/bmj.b2921","journal-title":"BMJ"},{"issue":"6","key":"key20240502115921_B4","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin- only contraceptive and thromboembolism: a systematic review","volume":"94","author":"Tepper","year":"2016","unstructured":"4. Tepper NK, Whiteman MK, Marchbanks PA, James AH, Curtis KM. Progestin- only contraceptive and thromboembolism: a systematic review. Contraception. 2016;94(6):678-700. doi: 10.1016\/j.contraception.2016.04.014","journal-title":"Contraception"},{"issue":"3","key":"key20240502115921_B5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/AOG.0b013e3181ec622b","article-title":"Levonorgestrel- releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial","volume":"116","author":"Kaunitz","year":"2010","unstructured":"5. Kaunitz AM, Bissonnette F, Monteiro I, Lukkari-Lax E, Muysers C, Jensen JT. Levonorgestrel- releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol. 2010;116(3):625-32. doi: 10.1097\/AOG.0b013e3181ec622b","journal-title":"Obstet Gynecol"},{"issue":"3","key":"key20240502115921_B6","first-page":"102","article-title":"Preven\u00e7\u00e3o de gesta\u00e7\u00f5es n\u00e3o planejadas com implante subd\u00e9rmico em mulheres da Cracol\u00e2ndia, S\u00e3o Paulo","volume":"30","author":"Sakamoto","year":"2015","unstructured":"6. Sakamoto LC, Malavasi AL, Karasin AL, Frajzinger RC, Ara\u00fajo MR, Gebrim LH. Preven\u00e7\u00e3o de gesta\u00e7\u00f5es n\u00e3o planejadas com implante subd\u00e9rmico em mulheres da Cracol\u00e2ndia, S\u00e3o Paulo. Reprod Clim. 2015;30(3):102-7. doi: 10.1016\/j.recli.2015.09.005","journal-title":"Reprod Clim"},{"key":"key20240502115921_B7","author":"Federa\u00e7\u00e3o Brasileira das Associa\u00e7\u00f5es de Ginecologia e Obstetr\u00edcia","year":"2021","unstructured":"7. Federa\u00e7\u00e3o Brasileira das Associa\u00e7\u00f5es de Ginecologia e Obstetr\u00edcia. M\u00e9todos anticoncepcionais revers\u00edveis de longa dura\u00e7\u00e3o. S\u00e3o Paulo: Febrasgo; 2021. (Comiss\u00e3o Nacional Especializada de Anticoncep\u00e7\u00e3o. Protocolo No. 64).","journal-title":"M\u00e9todos anticoncepcionais revers\u00edveis de longa dura\u00e7\u00e3o"},{"key":"key20240502115921_B8","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.769187","article-title":"Combined oral contraceptives and venous thromboembolism: review and perspective to mitigate the risk","volume":"12","author":"Morimont","year":"2021","unstructured":"8. Morimont L, Haguet H, Dogn\u00e9 JM, Gaspard U, Douxfils J. Combined oral contraceptives and venous thromboembolism: review and perspective to mitigate the risk. Front Endocrinol (Lausanne). 2021;12:769187. doi: 10.3389\/fendo.2021.769187","journal-title":"Front Endocrinol"},{"issue":"2","key":"key20240502115921_B9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/13625187.2022.2029397","article-title":"Confirmation of the safety of combined oral contraceptives containing oestradiol on the risk of venous thromboembolism","volume":"27","author":"Grandi","year":"2022","unstructured":"9. Grandi G, Facchinetti F, Bitzer J. Confirmation of the safety of combined oral contraceptives containing oestradiol on the risk of venous thromboembolism. Eur J Contracept Reprod Health Care. 2022;27(2):83-4. doi: 10.1080\/13625187.2022.2029397","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"5","key":"key20240502115921_B10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","unstructured":"10. Dinger JC, Heinemann LA, K\u00fchl-Habich D. The safety of a drospirenone containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation. Contraception. 2007;75(5):344-54. doi: 10.1016\/j.contraception.2006.12.019","journal-title":"Contraception"},{"issue":"5","key":"key20240502115921_B11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.contraception.2009.12.014","article-title":"Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10 years after the third generation \"pill scare\"","volume":"81","author":"Heinemann","year":"2010","unstructured":"11. Heinemann LA, Dinger JC, Assmann A, Minh TD. Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10 years after the third generation \"pill scare\". Contraception. 2010;81(5):401-7. doi: 10.1016\/j.contraception.2009.12.014","journal-title":"Contraception"},{"issue":"3","key":"key20240502115921_B12","article-title":"Consenso sobre a investiga\u00e7\u00e3o de trombofilia em mulheres e manejo cl\u00ednico","volume":"17","author":"Nascimento","year":"2019","unstructured":"12. Nascimento CM, Machado AM, Guerra JC, Zlotnik E, Camp\u00ealo DH, Kauffman P, et al. Consenso sobre a investiga\u00e7\u00e3o de trombofilia em mulheres e manejo cl\u00ednico. Einstein (S\u00e3o Paulo). 2019;17(3):eAE4510. doi: 10.31744\/einstein_journal\/2019AE4510","journal-title":"Einstein (S\u00e3o Paulo)"},{"issue":"1","key":"key20240502115921_B13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archinte.160.1.49","article-title":"Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects","volume":"160","author":"Bloemenkamp","year":"2000","unstructured":"13. Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects. Arch Intern Med. 2000;160(1):49-52. doi: 10.1001\/archinte.160.1.49","journal-title":"Arch Intern Med"},{"key":"key20240502115921_B14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.thromres.2020.05.008","article-title":"Estrogen and thrombosis: a bench to bedside review","volume":"192","author":"Abou-Ismail","year":"2020","unstructured":"14. Abou-Ismail MY, Citla Sridhar D, Nayak L. Estrogen and thrombosis: a bench to bedside review. Thromb Res. 2020;192:40-51. doi: 10.1016\/j.thromres.2020.05.008","journal-title":"Thromb Res"},{"issue":"1","key":"key20240502115921_B15","doi-asserted-by":"crossref","DOI":"10.7326\/AITC201907020","article-title":"Care of the transgender patient","volume":"171","author":"Safer","year":"2019","unstructured":"15. Safer JD, Tangpricha V. Care of the transgender patient. Ann Intern Med. 2019;171(1):ITC1. doi: 10.7326\/AITC201907020","journal-title":"Ann Intern Med"},{"issue":"1","key":"key20240502115921_B16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2105\/AJPH.2011.300315","article-title":"Transgender health in Massachusetts: results from a household probability sample of adults","volume":"102","author":"Conron","year":"2012","unstructured":"16. Conron KJ, Scott G, Stowell GS, Landers SJ. Transgender health in Massachusetts: results from a household probability sample of adults. Am J Public Health. 2012;102(1):118-22. doi: 10.2105\/AJPH.2011.300315","journal-title":"Am J Public Health"},{"key":"key20240502115921_B17","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-14-1224","article-title":"Monitoring the health of transgender and other gender minority populations: validity of natal sex and gender identity survey items in a U.S. national cohort of young adults","volume":"14","author":"Reisner","year":"2014","unstructured":"17. Reisner SL, Conron KJ, Tardiff LA, Jarvi S, Gordon AR, Austin SB. Monitoring the health of transgender and other gender minority populations: validity of natal sex and gender identity survey items in a U.S. national cohort of young adults. BMC Public Health. 2014;14:1224. doi: 10.1186\/1471-2458-14-1224","journal-title":"BMC Public Health"},{"key":"key20240502115921_B18","author":"Herman","year":"2022","unstructured":"18. Herman JL, Flores AR, O'Neill KK. How many adults and youth identify as transgender in the United States? [Internet]. 2022 [cited 2022 Oct 15]. Available from: https:\/\/williamsinstitute.law.ucla.edu\/wp-content\/uploads\/How-Many-Adults-Identify-as-Transgender-in-the-United-States.pdf","journal-title":"How many adults and youth identify as transgender in the United States?"},{"issue":"4","key":"key20240502115921_B19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jsxm.2016.02.001","article-title":"Prevalence of transgender depends on the \"case\" definition: a systematic review","volume":"13","author":"Collin","year":"2016","unstructured":"19. Collin L, Reisner SL, Tangpricha V, Goodman M. Prevalence of transgender depends on the \"case\" definition: a systematic review. J Sex Med. 2016;13(4):613-26. doi: 10.1016\/j.jsxm.2016.02.001","journal-title":"J Sex Med"},{"issue":"10042","key":"key20240502115921_B20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0140-6736(16)00683-8","article-title":"Transgender people: health at the margins of society","volume":"388","author":"Winter","year":"2016","unstructured":"20. Winter S, Diamond M, Green J, Karasic D, Reed T, Whittle S, et al. Transgender people: health at the margins of society. Lancet. 2016;388(10042):390-400. doi: 10.1016\/S0140-6736(16)00683-8","journal-title":"Lancet"},{"issue":"13","key":"key20240502115921_B21","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1056\/NEJMcp1008161","article-title":"Clinical practice. Care of transsexual persons","volume":"364","author":"Gooren","year":"2011","unstructured":"21. Gooren LJ. Clinical practice. Care of transsexual persons. N Engl J Med. 2011;364(13):1251-7. doi: 10.1056\/NEJMcp1008161","journal-title":"N Engl J Med"},{"issue":"2","key":"key20240502115921_B22","first-page":"55","article-title":"Hormone therapy in transgender adults is safe with provider supervision; a review of hormone therapy sequelae for transgender individuals","volume":"2","author":"Weinand","year":"2015","unstructured":"22. Weinand JD, Safer JD. Hormone therapy in transgender adults is safe with provider supervision; a review of hormone therapy sequelae for transgender individuals. J Clin Transl Endocrinol. 2015;2(2):55-60. doi: 10.1016\/j.jcte.2015.02.003","journal-title":"J Clin Transl Endocrinol"},{"key":"key20240502115921_B23","first-page":"31","article-title":"Hormone treatment of the adult transsexual patient","volume":"64","author":"Gooren","year":"2005","unstructured":"23. Gooren L. Hormone treatment of the adult transsexual patient. Horm Res. 2005;64 Suppl 2:31-6. doi: 10.1159\/000087751","journal-title":"Horm Res"},{"issue":"4","key":"key20240502115921_B24","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/GRF.0000000000000396","article-title":"Gender-affirming hormone therapy for transgenders female","volume":"61","author":"Randolph","year":"2018","unstructured":"24. Randolph JF Jr. Gender-affirming hormone therapy for transgenders female. Clin Obstet Gynecol. 2018;61(4):705-21. doi: 10.1097\/GRF.0000000000000396","journal-title":"Clin Obstet Gynecol"},{"issue":"13","key":"key20240502115921_B25","first-page":"484","article-title":"Morbidity in transsexual patients with cross-gender hormone self-treatment","volume":"113","author":"Becerra Fern\u00e1ndez","year":"1999","unstructured":"25. Becerra Fern\u00e1ndez A, de Luis Rom\u00e1n DA, Pi\u00e9drola Maroto G. [Morbidity in transsexual patients with cross-gender hormone self-treatment]. Med Clin (Barc). 1999;113(13):484-7. Spanish.","journal-title":"Med Clin (Barc)"},{"issue":"4","key":"key20240502115921_B26","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-023549","article-title":"Thrombosis risk in transgender adolescents receiving gender-affirming hormone therapy","volume":"147","author":"Mullins","year":"2021","unstructured":"26. Mullins ES, Geer R, Metcalf M, Piccola J, Lane A, Conard LA, et al. Thrombosis risk in transgender adolescents receiving gender-affirming hormone therapy. Pediatrics. 2021;147(4):e2020023549. doi: 10.1542\/peds.2020-023549","journal-title":"Pediatrics"},{"issue":"7","key":"key20240502115921_B27","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/and.12150","article-title":"Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review","volume":"46","author":"Asscheman","year":"2014","unstructured":"27. Asscheman H, T'Sjoen G, Lemaire A, Mas M, Meriggiola MC, Mueller A, et al. Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review. Andrologia. 2014;46(7):791-5. doi: 10.1111\/and.12150","journal-title":"Andrologia"},{"issue":"4","key":"key20240502115921_B28","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/EJE-10-1038","article-title":"A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones","volume":"164","author":"Asscheman","year":"2011","unstructured":"28. Asscheman H, Giltay EJ, Megens JA, de Ronde WP, van Trotsenburg MA, Gooren LJ. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. Eur J Endocrinol. 2011;164(4):635-42. doi: 10.1530\/EJE-10-1038","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"key20240502115921_B29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1530\/EJE-13-0493","article-title":"Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study","volume":"169","author":"Wierckx","year":"2013","unstructured":"29. Wierckx K, Elaut E, Declercq E, Heylens G, De Cuypere G, Taes Y, et al. Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study. Eur J Endocrinol. 2013;169(4):471-8. doi: 10.1530\/EJE-13-0493","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"key20240502115921_B30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M17-2785","article-title":"Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study","volume":"169","author":"Getahun","year":"2018","unstructured":"30. Getahun D, Nash R, Flanders WD, Baird TC, Becerra-Culqui TA, Cromwell L, et al. Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study. Ann Intern Med. 2018;169(4):205-13. doi: 10.7326\/M17-2785","journal-title":"Ann Intern Med"},{"issue":"10","key":"key20240502115921_B31","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1111\/j.1743-6109.2012.02876.x","article-title":"Long-term evaluation of cross-sex hormone treatment in transsexual persons","volume":"9","author":"Wierckx","year":"2012","unstructured":"31. Wierckx K, Mueller S, Weyers S, Van Caenegem E, Roef G, Heylens G, et al. Long-term evaluation of cross-sex hormone treatment in transsexual persons. J Sex Med. 2012;9(10):2641-51. doi: 10.1111\/j.1743-6109.2012.02876.x","journal-title":"J Sex Med"},{"issue":"3","key":"key20240502115921_B32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.blre.2016.12.001","article-title":"How do you decide on hormone replacement therapy in women with risk of venous thromboembolism?","volume":"31","author":"Lekovic","year":"2017","unstructured":"32. Lekovic D, Miljic P, Dmitrovic A, Thachil J. How do you decide on hormone replacement therapy in women with risk of venous thromboembolism? Blood Rev. 2017;31(3):151-7. doi: 10.1016\/j.blre.2016.12.001","journal-title":"Blood Rev"},{"issue":"9337","key":"key20240502115921_B33","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(02)11032-4","article-title":"Evidence from randomized trials on the long-term effects of hormone replacement therapy","volume":"360","author":"Beral","year":"2002","unstructured":"33. Beral V, Banks E, Reeves G. Evidence from randomized trials on the long-term effects of hormone replacement therapy. Lancet. 2002;360(9337):942-4. doi: 10.1016\/S0140-6736(02)11032-4","journal-title":"Lancet"},{"issue":"7","key":"key20240502115921_B34","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study","volume":"115","author":"Canonico","year":"2007","unstructured":"34. Canonico M, Orger E, Plu-Bureau G, Conard J, Meyer G, L\u00e9vesque H, et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation. 2007;115(7):840-5. doi: 10.1161\/CIRCULATIONAHA.106.642280","journal-title":"Circulation"},{"key":"key20240502115921_B35","article-title":"Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"364","author":"Vinogradova","year":"2019","unstructured":"35. Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ. 2019;364:k4810. doi: 10.1136\/bmj.k4810","journal-title":"BMJ"},{"issue":"6","key":"key20240502115921_B36","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/13697137.2022.2127352","article-title":"Pulmonary embolism in menopausal hormone therapy: a population-based register study","volume":"25","author":"Sundell","year":"2022","unstructured":"36. Sundell M, Spetz Holm AC, Fredrikson M, Hammar M, Hoffmann M, Brynhildsen J. Pulmonary embolism in menopausal hormone therapy: a population-based register study. Climacteric. 2022;25(6):615-21. doi: 10.1080\/13697137.2022.2127352","journal-title":"Climacteric"},{"issue":"7","key":"key20240502115921_B37","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0800743","article-title":"The effects of tibolone in older postmenopausal women","volume":"359","author":"Cummings","year":"2008","unstructured":"37. Cummings SR, Ettinger B, Delmas PD, Kenemans P, Stathopoulos V, Verweij P, et al. The effects of tibolone in older postmenopausal women. N Engl J Med. 2008;359(7):697-708. doi: 10.1056\/NEJMoa0800743","journal-title":"N Engl J Med"},{"issue":"7","key":"key20240502115921_B38","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41443-022-00613-0","article-title":"The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review","volume":"34","author":"Uloko","year":"2022","unstructured":"38. Uloko M, Rahman F, Puri LI, Rubin RS. The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review. Int J Impot Res. 2022;34(7):635-41. doi: 10.1038\/s41443-022-00613-0","journal-title":"Int J Impot Res"},{"issue":"8","key":"key20240502115921_B39","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.3390\/jcm9082467","article-title":"Prevention of venous thromboembolism in 2020 and beyond","volume":"9","author":"Nicholson","year":"2020","unstructured":"39. Nicholson M, Chan N, Bhagirath V, Ginsberg J. Prevention of venous thromboembolism in 2020 and beyond. J Clin Med. 2020;9(8):2467. doi: 10.3390\/jcm9082467","journal-title":"J Clin Med"},{"issue":"2","key":"key20240502115921_B40","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/1358863X17690601","article-title":"Pregnancy, contraception and venous thromboembolism (deep vein thrombosis and pulmonary embolism)","volume":"22","author":"James","year":"2017","unstructured":"40. James AH. Pregnancy, contraception and venous thromboembolism (deep vein thrombosis and pulmonary embolism). Vasc Med. 2017;22(2):166-9. doi: 10.1177\/1358863X17690601","journal-title":"Vasc Med"}],"container-title":["Revista Brasileira de Ginecologia e Obstetr\u00edcia \/ RBGO Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journalrbgo.org\/wp-content\/uploads\/sites\/4\/articles_xml\/1806-9339-rbgo-46-e-FPS02\/1806-9339-rbgo-46-e-FPS02.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T16:52:24Z","timestamp":1724345544000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalrbgo.org\/article\/use-of-hormones-and-risk-of-venous-thromboembolism\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":40,"alternative-id":["10.61622\/rbgo\/2024FPS02"],"URL":"https:\/\/doi.org\/10.61622\/rbgo\/2024fps02","relation":{},"ISSN":["0100-7203","1806-9339"],"issn-type":[{"value":"0100-7203","type":"print"},{"value":"1806-9339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e-FPS02"}}